The Different Stages Of The Eradication Of HIV
“The primary etiologic agent of AIDS is HIV, an enveloped ribonucleic acid (RNA) retrovirus that carries its genetic material in RNA rather than DNA.” (Porth, 2015, p. 363) There are two different forms of HIV; HIV-1 and HIV-2. The human immunodeficiency virus-1 is the virus mostly …show more content…
Acute infection is the first stage, which is when the person comes into contact with HIV. Typically two to four weeks after a person comes in contact with the virus flu like symptoms being to present themselves, although not everybody that gets HIV will have these symptoms. Symptoms include fatigue, fever, rash, swollen glands, joint aches, sore throat and a headache. During this period the eight steps of HIV replication begin. Because mass amounts of infected cells are being produced the disease is so easily passed from person to person because they are unaware they are infected.
Stage two is referred to as the latency period. The latency period can go on for many years, and with the progression in medicine and research behind HIV, the latency period is only continuing to grow. During the latency period an infected person is said to be asymptomatic. While the virus is still very active and continually proliferating the remaining healthy CD4 cells during the latency stage, not as many symptoms are present, and if any are they are said to be very …show more content…
The only things ever changing are the manifestations and treatment for HIV. With the advances in science around the world, the manifestation of the virus is able to significantly slow down and hopefully one day cease to exist. Until that day comes, scientists are continually inventing new medications that can stop certain and all parts of the HIV process in hopes to either prolong the latency period or prevent the overt AIDS period from ever happening.
Alessia Carbone, A. L. (2014). Dolutegravir: a new option for HIV treatment. Furture Virology, 801.
Darren Wong, R. G. (2015). Tenofovir alafenamide: an effective option for HIV treatment with reduced risk. Furture Virology, 1069.
Naseem Cassim, L. M. (2016). Compliance to HIV Treatment Monitoring Guidelines can Rduce Laboratory Costs. Southern African Journal of HIV Medicine.
Patil, V. C., & Patil, H. V. (2016). Clinical manifestations and outcome of patients with human immunodeficiency virus infection at tertiary care teaching hospital.. Indian Journal of Sexually Transmitted Diseases and AIDS, 38-45.
Porth, C. M. (2015). Essentials of Pathophysiology. Philadelphia: Lisa